Immunomedics Warns Biosimilar Chasers Over Trodelvy

Sacituzumab Biologic Brand Was Approved By FDA In April

 
• By Dean Rudge
  
Barrier
The task of proving equivalence to complex biologics is well documented in the industry • Source: Shutterstock

More from Biosimilars

More from Products